Actavis Launches Lercanidipine In Major European Markets
Actavis has launched the product under its own brand name on day one in the UK and France, where the patents expired on 20 and 21 January, respectively.
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.